Fenofibrate - Vectura
Alternative Names: TriglideLatest Information Update: 02 Oct 2021
Price :
$50 *
At a glance
- Originator SkyePharma Canada; SkyePharma PLC
- Developer Vectura
- Class Antihyperlipidaemics; Benzophenones; Butyric acids; Fibric acid derivatives; Propionates; Small molecules
- Mechanism of Action Peroxisome proliferator-activated receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Marketed Cardiovascular disorders; Hypercholesterolaemia; Hyperlipidaemia
Most Recent Events
- 12 Jan 2010 Sciele Pharma is now called Shionogi Pharma
- 09 Oct 2008 Sciele Pharma has been acquired by Shionogi
- 16 Jun 2006 First Horizon Pharmaceutical Corporation is now called Sciele Pharma